Clinical Trial Update: Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating perioperative S-1 plus docetaxel in localized advanced gastric cancer; the update notes the study status as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Stomach Neoplasms | Phase 2 | Status: UNKNOWN